Healthcare Realty Trust Statistics
Total Valuation
HR has a market cap or net worth of $7.51 billion. The enterprise value is $11.82 billion.
| Market Cap | 7.51B |
| Enterprise Value | 11.82B |
Important Dates
The next confirmed earnings date is Thursday, July 30, 2026, after market close.
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | May 11, 2026 |
Share Statistics
HR has 350.77 million shares outstanding. The number of shares has decreased by -2.46% in one year.
| Current Share Class | 346.52M |
| Shares Outstanding | 350.77M |
| Shares Change (YoY) | -2.46% |
| Shares Change (QoQ) | -0.75% |
| Owned by Insiders (%) | 0.59% |
| Owned by Institutions (%) | 111.05% |
| Float | 344.17M |
Valuation Ratios
| Price/FFO Ratio | 15.47 |
| Price/AFFO Ratio | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.47 |
| Forward PS | 6.68 |
| PB Ratio | 1.67 |
| P/TBV Ratio | 1.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 16.24 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.18 |
| EV / EBITDA | 18.65 |
| EV / EBIT | 128.72 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.31, with a Debt / Equity ratio of 0.97.
| Current Ratio | 0.31 |
| Quick Ratio | 0.04 |
| Debt / Equity | 0.97 |
| Debt / EBITDA | 6.85 |
| Debt / FCF | n/a |
| Interest Coverage | 0.45 |
Financial Efficiency
Return on equity (ROE) is -4.23% and return on invested capital (ROIC) is 0.70%.
| Return on Equity (ROE) | -4.23% |
| Return on Assets (ROA) | 0.68% |
| Return on Invested Capital (ROIC) | 0.70% |
| Return on Capital Employed (ROCE) | 1.10% |
| Weighted Average Cost of Capital (WACC) | 6.91% |
| Revenue Per Employee | $2.15M |
| Profits Per Employee | -$378,126 |
| Employee Count | 539 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +29.38% in the last 52 weeks. The beta is 0.82, so HR's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | +29.38% |
| 50-Day Moving Average | 20.43 |
| 200-Day Moving Average | 18.48 |
| Relative Strength Index (RSI) | 62.73 |
| Average Volume (20 Days) | 3,505,226 |
Short Selling Information
The latest short interest is 20.32 million, so 5.79% of the outstanding shares have been sold short.
| Short Interest | 20.32M |
| Short Previous Month | 16.18M |
| Short % of Shares Out | 5.79% |
| Short % of Float | 5.90% |
| Short Ratio (days to cover) | 4.63 |
Income Statement
In the last 12 months, HR had revenue of $1.16 billion and -$203.81 million in losses. Loss per share was -$0.58.
| Revenue | 1.16B |
| Gross Profit | 719.68M |
| Operating Income | 106.38M |
| Pretax Income | -204.08M |
| Net Income | -203.81M |
| EBITDA | 633.80M |
| EBIT | 91.81M |
| Loss Per Share | -$0.58 |
Balance Sheet
The company has $28.59 million in cash and $4.34 billion in debt, with a net cash position of -$4.31 billion or -$12.29 per share.
| Cash & Cash Equivalents | 28.59M |
| Total Debt | 4.34B |
| Net Cash | -4.31B |
| Net Cash Per Share | -$12.29 |
| Equity (Book Value) | 4.50B |
| Book Value Per Share | 12.81 |
| Working Capital | -540.78M |
Cash Flow
| Operating Cash Flow | 462.18M |
| Capital Expenditures | -322.18M |
| Depreciation & Amortization | 536.92M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 61.99%, with operating and profit margins of 9.16% and -17.34%.
| Gross Margin | 61.99% |
| Operating Margin | 9.16% |
| Pretax Margin | -17.58% |
| Profit Margin | -17.34% |
| EBITDA Margin | 55.29% |
| EBIT Margin | 8.01% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $0.96, which amounts to a dividend yield of 4.49%.
| Dividend Per Share | $0.96 |
| Dividend Yield | 4.49% |
| Dividend Growth (YoY) | -22.58% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.46% |
| Shareholder Yield | 7.00% |
| Earnings Yield | -2.72% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for HR is $21.33, which is -0.33% lower than the current price. The consensus rating is "Hold".
| Price Target | $21.33 |
| Price Target Difference | -0.33% |
| Analyst Consensus | Hold |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 1.79% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |